Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Medicine (Baltimore)
; 95(9): e2947, 2016 Mar.
Article
en En
| MEDLINE
| ID: mdl-26945407
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Fármacos Cardiovasculares
/
Factor Natriurético Atrial
/
Insuficiencia Cardíaca
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2016
Tipo del documento:
Article